2 results
Approved WMOCompleted
To evaluate the effect of Obeticholic Acid on clinical outcomes in subjects with primary biliary cholangitis
Approved WMORecruiting
This Phase Ia/Ib study will evaluate the safety, pharmacokinetics, immunogenicity (as applicable for study biotherapeutics), preliminary activity, and biomarkers of GDC-6036 as a single agent (Arm A) and in combination with other anti-cancer…